Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Buffalo, New York 14263


The purpose of this study is to explore the use of an prolonged alternative dosing schedule using varenicline for smoking cessation leading to greater quit rates and higher rates of continuous abstinence.

Study summary:

This pilot study will utilize a two group randomized design. Adult smokers who are motivated to quit smoking will be randomized to one of two treatment groups. Both groups will receive brief support counseling. During a one-week baseline and the 4-week pre-quit period smoking rate, smoking satisfaction, withdrawal, and craving will be assessed on a daily basis.


Inclusion Criteria: - currently smoking at least 15 cigarettes daily - in good health - able to read and speak English fluently - have a home telephone and plan to reside in Western New York for 6 months - willing to make quit attempt - signed informed consent - who planned quit attempt. Exclusion Criteria: - serious medical condition - depression or mental health condition requiring treatment in the past year - history of panic disorder, psychosis, bipolar disorder - alcohol or drug abuse in the past year - use of tobacco products other than cigarettes - current use of other cessation pharmacotherapies - pregnancy/planned pregnancy.



Primary Contact:

Principal Investigator
Martin C Mahoney, MD, PhD
Roswell Park Cancer Institute

Backup Contact:


Location Contact:

Buffalo, New York 14263
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.